Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
---|---|---|---|---|---|---|
Salix Pharmaceuticals | Methylnaltrexone | Relistor | 2024-04-08 | 2008-04-24 | ||
Plecanatide | Trulance | 2022-03-28 | 2017-01-19 | |||
Ascorbic acid, Polyethylene glycol 3350, Ascorbate | Moviprep | 2024-09-01 | 2006-08-02 | |||
Ascorbic acid, Polyethylene glycol 3350, Ascorbate | Plenvu | 2032-03-09 | 2018-05-04 | |||
Teva | Lactulose | Evalose | 1993-05-28 | |||
Lactulose | Heptalac | 1993-05-28 | ||||
Lubiprostone | Lubiprostone | 2022-01-18 | ||||
Mylan | Linaclotide | Linaclotide | 2021-02-09 | |||
Polyethylene glycol 3350 | Colyte With Flavor Packs | 1984-10-26 | ||||
AbbVie | Linaclotide | Constella | 2012-11-26 | |||
Linaclotide | Linzess | 2024-01-28 | 2012-08-30 | $954 M | Y2024 | |
Sanofi | Lactulose | Cephulac | 1982-01-01 | |||
Lactulose | Chronulac | 1982-01-01 | ||||
Bausch Health Companies | Methylnaltrexone | Relistor | 2008-07-01 | |||
Xttrium Laboratories | Lactulose | Lactulose | 2002-02-21 | |||
Takeda | Prucalopride | Motegrity | 2018-12-14 | |||
Prucalopride | Resolor | 2009-10-14 | ||||
Dr Reddys Laboratories | Lubiprostone | Lubiprostone | 2022-02-08 |
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
---|---|---|---|---|---|